Brevan Howard Capital Management LP Pulmonx Corp Transaction History
Brevan Howard Capital Management LP
- $9.23 Billion
- Q1 2025
A detailed history of Brevan Howard Capital Management LP transactions in Pulmonx Corp stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 15,238 shares of LUNG stock, worth $47,847. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,238Holding current value
$47,847% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LUNG
# of Institutions
127Shares Held
32.5MCall Options Held
2.6KPut Options Held
216K-
Primecap Management CO Pasadena, CA5.41MShares$17 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.49MShares$11 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$8.38 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$7.17 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.89MShares$5.93 Million0.32% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $117M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...